Michael Freeman, associate director and business unit head for lab services at Alcami, recently contributed to an article in Drug Development & Delivery titled Outsourcing Analytical Testing: Novel Services Elicit Consistent, Quantifiable, & Faster Results. In the article, Freeman explains how Alcami's end-to-end analytical testing platform supports client programs through every stage of a product's lifecycle, from early phase development activities to commercial support for both small and large molecule products.
MORE CONTENT RELATED TO ANALYTICAL TESTING SERVICES
- The Benefits of Establishing a Full-Time Equivalent (FTE) Program with Your Contract Service Provider
- ON-DEMAND WEBINAR: Alcami Introduces Rapid Sterility
- Regulatory Requirements for Early Phase Drug Product Development
- Video: Extractables and Leachables
- Stability: Top Testing Factors You Should Consider
- White Paper: Structural Characterization of Biologics Using High-Resolution Mass Spectrometry
Ready to Get Started?